Trials / Conditions / Calcific Uremic Arteriolopathy
Calcific Uremic Arteriolopathy
7 registered clinical trials studyying Calcific Uremic Arteriolopathy — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Calciphylaxis in Patients With Chronic Kidney Disease - A Study of the Danish Calciphylaxis Research Initiativ NCT07511283 | Odense University Hospital | — |
| Completed | Phase 3 Study of SNF472 for Calciphylaxis NCT04195906 | Sanifit Therapeutics S. A. | Phase 3 |
| Recruiting | Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis NCT04592640 | The First Affiliated Hospital with Nanjing Medical University | EARLY_Phase 1 |
| Recruiting | Partners Calciphylaxis Biobank NCT03032835 | Massachusetts General Hospital | — |
| Completed | Phase 2 Study With SNF472 in Calciphylaxis Patients NCT02790073 | Sanifit Therapeutics S. A. | Phase 2 |
| Completed | Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy NCT02278692 | Massachusetts General Hospital | N/A |
| Withdrawn | Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopa NCT02527213 | American Regent, Inc. | Phase 3 |